Tarabios is developing a mobile device to monitor blood clot times (PT/INR) for Warfarin Therapy patients and will market the device soon. Its patented mechanical meaurement system can measure the viscosity of the blood on a cartridge with mircofluidic channel. The platform technology will further be developed to enable multiplexed, low cost, easy to use point-of-need tests for many more diseases.
| Website | http://www.tarabios.com |
| Revenue | $2 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2020 |
| Phone | +90 532 705 08 20 |
| Technologies |
JavaScript
,
HTML
,
Microsoft Outlook
+2 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Anticoagulation Management, Microfluidic Technology, Point Of Care Testing, Thrombosis Prevention, Medical Device Development, Healthcare Technology, Medical Technology, Digital Health |
| Competitors | Roche, Novartis, Merck & Co., Inc., Pfizer, Sanofi, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Gilead Sciences +46 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 325413 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Tarabios employee's phone or email?
Tarabios Questions
The Tarabios annual revenue was $2 million in 2026.
Tarabios is based in Berlin, Berlin.
The NAICS codes for Tarabios are [325, 325413, 32541, 32, 3254].
The SIC codes for Tarabios are [28, 283].
Related Companies
